This article reviews the pathology and prevention for in-stent restenosis.
现就支架再狭窄的病理及其防治作一综述。
In-stent restenosis has been significantly reduced by utilization of drug eluting stents.
药物涂层支架的应用显著降低了支架内再狭窄的发生。
In-stent restenosis is the major factor influencing the results of percutaneous coronary intervention.
支架内再狭窄是影响经皮冠状动脉介入治疗疗效的主要原因。
Paclitaxel-Coated Balloon Catheter Versus Paclitaxel-Coated Stent for the Treatment of Coronary In-Stent Restenosis.
涂渍紫杉醇的球囊导管与涂渍紫杉醇的支架在治疗支架内在狭窄中的比较。
The in-stent restenosis is one of the main complications in coronary artherosclerotic heart disease patients after PTCA and PCI.
术后靶血管管腔再狭窄是冠状动脉介入治疗术的主要并发症，如何有效预防再狭窄已成为目前介入心脏医学界的主要课题之一。
Objective To assess the safety and therapeutical efficiency of dual-wire balloon using in treating coronary artery in-stent restenosis.
目的评价双导丝球囊在冠脉支架内再狭窄治疗中的的安全性和疗效。
Objective To evaluate the safety and efficacy of cutting balloon angioplasty (CBA) for diffuse in-stent restenosis (ISR) in elderly patients.
目的研究切割球囊成形术（CBA）治疗高龄患者弥漫性冠状动脉（冠脉）支架内再狭窄（ISR）的安全性与疗效。
Objective To explore the experience about off-pump coronary artery bypass grafting (OPCAB) for the treatment of in-stent restenosis in coronary disease.
目的探讨非体外循环冠状动脉旁路移植术(OPCAB)对老年冠心病患者冠状动脉支架再狭窄的治疗经验。
Objective to assess the accuracy and the clinical value of dual-source computed tomography (DSCT) for detecting in-stent restenosis of the coronary arteries.
目的评估双源ct在冠状动脉支架置入术后再狭窄诊断的准确度，评价其在支架置入术后复查中的临床随访价值。
The use of SES implantation was not restricted to "on-label" indications, and target lesions included in-stent restenosis, vein graft, left main stem locations, bifurcations, and long lesions.
SES置入不受“标签”适应证的限制，靶病变包括支架内再狭窄、静脉搭桥、左主干局部病变、分叉病变和长病变。
Objective:To develop an experimental animal model that accurately mimics human coronary restenosis in normal mini swine by implantation of oversized intracoronary stent.
目的：用置入过大直径冠状动脉内支架的方法，在正常小型猪建立模拟人类冠状动脉再狭窄的实验动物模型。
The purpose of this article is to review the relevant preclinical and clinical data in the field of rapamycin eluting stent for the prevention of restenosis.
本文就目前雷帕霉素涂层支架在临床防治再狭窄研究的最新进展作一综述。
The treatment of in stent restenosis includes balloon dilation, directional atherectomy, rotational atherectomy, cutting balloon, additional stent and radiation therapy.
安放支架后再狭窄的治疗可应用球囊扩张、旋切术、旋磨术、切割球囊、再次安放支架和放射治疗。
Objective to observe the effects of pioglitazone on stent restenosis in coronary heart disease patients with impaired glucose tolerance.
目的观察吡格列酮对冠心病合并糖耐量异常患者冠脉支架内再狭窄的影响。
The artery in which the stent is placed, however, can become blocked again during a process called restenosis. This re-closure means a repeat surgery.
而置入支架的血管可因一种叫做再狭窄的过程而再次闭塞，这就意味着要二次手术。
Objective To investigate the predictors of in stent restenosis in coronary artery.
目的探讨冠状动脉内支架再狭窄的相关因素。
Conclusion Drug-eluting stent implantation can decrease the rate of restenosis significantly in coronary intervention.
结论药物涂层支架置入可显著降低冠脉介入术后再狭窄率。
Coronary angiography was performed at the 6th month. The late lumen loss, stent restenosis and major adverse cardiac events were compared in both groups.
术后6个月重复冠状动脉造影，比较两组间的晚期管腔丢失、支架再狭窄率及术后心血管不良事件发生率。
ObjectiveTo observe the effect of Tongxinfang on coronary collateral formation and stent-restenosis in patients with coronary artery disease after stenting.
目的观察中药对冠心病支架术后缺血心肌血管新生以及支架再狭窄的临床疗效。
To prevent restenosis following stenting, and design stent with better curative effect and less side effects are subjects in future studies.
因此，防止气道支架置入后再狭窄的发生及其处理， 开发疗效更好、副作用更少的新支架是今后研究的热点方向。
To prevent restenosis following stenting, and design stent with better curative effect and less side effects are subjects in future studies.
因此，防止气道支架置入后再狭窄的发生及其处理， 开发疗效更好、副作用更少的新支架是今后研究的热点方向。
应用推荐